Urology · Largo, MD
NPI
1053775171
Since 2016
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1221 Mercantile Ln
Largo, MD, 20774
Phone (301) 618-5500
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,107
186 services
Medicare patients, 2024
38
Average age 71
Drug cost, 2024
$77K
1,278 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Samantha Nealon prescribed most often to Medicare patients was Tamsulosin Hcl, with 246 prescriptions and refills. In total Samantha Nealon wrote 1,278 Medicare prescriptions that cost $77K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-25.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tamsulosin Hcl Generic | 246 | 608 | 112 | $3,408 |
| Trospium Chloride Generic | 129 | 253 | 55 | $4,341 |
| Estradiol Generic | 86 | 136 | 52 | $4,062 |
| Phenazopyridine Hcl Generic | 81 | 83 | 54 | $971 |
| Myrbetriq Mirabegron | 73 | 97 | 22 | $44K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 73 | 173 | 42 | $1,291 |
| Oxycodone Hcl Generic | 70 | 70 | 57 | $471 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 67 | 67 | 52 | $424 |
| Cefdinir Generic | 50 | 50 | 36 | $1,014 |
| Solifenacin Succinate Generic | 45 | 73 | 14 | $1,140 |
| Levofloxacin Generic | 44 | 44 | 38 | $253 |
| Gabapentin Generic | 28 | 32 | 21 | $200 |
| Mirabegron Er Mirabegron | 28 | 32 | 17 | $7,385 |
| Tadalafil Generic | 24 | 28 | Under 11 | $281 |
| Nystatin Generic | 20 | 20 | Under 11 | $767 |
Brand drugs: 78 claims; generic drugs: 1,119 claims; opioid claims: 71.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Samantha Nealon were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.